Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01256
|
|||||
| Drug Name |
Succimer
|
|||||
| Synonyms |
(2R,3S)-rel-2,3-Dimercaptosuccinic acid; (R*,S*)-2,3-Dimercaptobutanedioic acid; 304-55-2; BRN 1725150; Butanedioic acid, 2,3-dimercapto-, (2R,3S)-rel-; Butanedioic acid, 2,3-dimercapto-, (R*,S*)-; CHEBI:63623; Chemet; DMSA; DX1U2629QE; Dim-sa; Dimercaptosuccinic acid; EINECS 206-155-2; HSDB 6783; Ro 1-7977; Succimer; Succimer [USAN:INN:BAN]; Succimero; Succimero [INN-Spanish]; Succimerum; Succimerum [INN-Latin]; UNII-DX1U2629QE; meso-2,3-Dimercaptobernsteinsaeure; meso-2,3-Dimercaptosuccinic acid; meso-Dimercaptosuccinic acid
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Lead poisoning [ICD11: NE61] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C4H6O4S2
|
|||||
| Canonical SMILES |
C(C(C(=O)O)S)(C(=O)O)S
|
|||||
| InChI |
InChI=1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+
|
|||||
| InChIKey |
ACTRVOBWPAIOHC-XIXRPRMCSA-N
|
|||||
| CAS Number |
CAS 304-55-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 182.2 | Topological Polar Surface Area | 76.6 | ||
| Heavy Atom Count | 10 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
0.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:63623
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [2] | |
| References | ||||||
| 1 | Gadobenate dimeglumine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):10-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.